Goal: Determine the rate of clinical and subclinical characteristics of community acquired pneumonia (CAP) in children older than 5 years old and in cases of atypical pneumonia, prevalence of Mycoplasma pneumoniae (MP) and Chlamydophila pneumoniae (CP) and the rate of treament outcome.